152 related articles for article (PubMed ID: 8868311)
1. Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patients.
Baldoncini R; Ferri C; Bellini C; Desideri G; De Angelis C; Santucci A
Clin Invest Med; 1996 Feb; 19(1):13-9. PubMed ID: 8868311
[TBL] [Abstract][Full Text] [Related]
2. [Relation of atrial natriuretic peptide and endogenous digoxin-like activity in the plasma of young hypertensive patients].
Musca A; Ferri C; Cammarella S; Tani S; Valentino S; Santucci A
Medicina (Firenze); 1989; 9(3):304-6. PubMed ID: 2533312
[TBL] [Abstract][Full Text] [Related]
3. [Variations in the plasma concentrations of atrial natriuretic factor and endogenous digitalis compounds during acute volume expansion in the conscious rat].
Morris M; Devynck MA; Pernollet MG; Meyer P
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():105-8. PubMed ID: 2847669
[TBL] [Abstract][Full Text] [Related]
4. The effect of human atrial natriuretic peptide on urinary sodium and urinary dopamine excretion in man.
Struthers AD; Anderson JV; Causon RC; Christofides ND; Bloom SR
J Hypertens Suppl; 1985 Dec; 3(3):S315-7. PubMed ID: 2856726
[TBL] [Abstract][Full Text] [Related]
5. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome.
Hisanaga S; Yamamoto Y; Kida O; Kato J; Fujimoto S; Tanaka K
Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):661-9. PubMed ID: 2529385
[TBL] [Abstract][Full Text] [Related]
7. Enhanced secretion and impaired natriuretic action of atrial natriuretic peptide in response to hypertonic saline infusion in patients with essential hypertension.
Akaike M; Nishiuchi T; Matsumoto N; Kawai H; Saito S
J Hum Hypertens; 1994 Jan; 8(1):15-8. PubMed ID: 8151600
[TBL] [Abstract][Full Text] [Related]
8. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of atrial natriuretic peptide and digoxin-like immunoreactive substances in intermittent peritoneal dialysis.
Korzets Z; Pomeranz M; Shilo L; Pomeranze A; Levi A; Shenkman L; Berheim J
Adv Perit Dial; 1989; 5():20-3. PubMed ID: 2577411
[TBL] [Abstract][Full Text] [Related]
10. Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
Burnier M; Mooser V; Wauters JP; Marder HK; De Vane P; Nussberger J; Waeber B; Brunner HR
J Cardiovasc Pharmacol; 1989 May; 13(5):682-90. PubMed ID: 2472515
[TBL] [Abstract][Full Text] [Related]
11. [Role of atrial natriuretic peptide in the renal response to acute volume expansion in the normal and essential hypertensive patient].
Mimran A; Nussberger J; Ribstein J; Waeber B; Brunner HR
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():101-4. PubMed ID: 2973295
[TBL] [Abstract][Full Text] [Related]
12. The role of endogenous digitalis-like factor in blood pressure regulation in essential hypertension.
Suchmanová-Lazúrová I; Lichardus B; Rosochová I; Pjescák M; Trejbal D; Murár J; Machánová Y
Wien Klin Wochenschr; 1994; 106(16):513-6. PubMed ID: 7975661
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide (ANP) responsiveness in patients with hypothyroidism.
Barna I; Földes J; Tóth M; Büki B; Lang RE; De Châtel R
Acta Med Hung; 1994; 50(1-2):23-32. PubMed ID: 7638038
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
15. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
16. The kidney and essential hypertension.
Balsano F
Ann Ital Med Int; 1991; 6(1 Pt 2):93-106. PubMed ID: 1835873
[TBL] [Abstract][Full Text] [Related]
17. Effects of infusing alpha-atrial natriuretic peptide in primary hypertension during converting enzyme inhibition.
Agabiti-Rosei E; Castellano M; Beschi M; Muiesan ML; Romanelli G; Rizzoni D; Muiesan G
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S151-3. PubMed ID: 2485053
[TBL] [Abstract][Full Text] [Related]
18. A possible physiological role of atrial natriuretic peptide in body fluid volume regulation.
Hirata Y; Ishii M; Fukui K; Hayakawa H; Namba S; Dan Y; Ishimitsu T; Sugimoto T; Kimura K; Matsuoka H
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S63-8. PubMed ID: 2473354
[TBL] [Abstract][Full Text] [Related]
19. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
[TBL] [Abstract][Full Text] [Related]
20. Effect of rapid intra-atrial saline infusion on atrial pressures and atrial natriuretic hormone secretion.
Shenker Y; Wesly J; Meranda D; Kosolcharoen P
Horm Metab Res; 1997 Jan; 29(1):33-7. PubMed ID: 9049652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
